Search research articles
Contact Us
Filters
Showing results (251-260 of 272) with videos related to
Page
of 28
Sort By:
Chemistry & Biology
|
September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells
Jared J Barrott, Philip F Hughes, Takuya Osada, et al.
Oncogene
|
May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
J Turpin, C Ling, E J Crosby, et al.
Human Vaccines & Immunotherapeutics
|
February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer
Gabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 27, 2026
Enhanced Efficacy of a Next-Generation EEEV Self-Replicating RNA Platform for Combination Cancer Immunotherapies
Shigeki J Miyake-Stoner, Christian J Maine, Annie C Chou, et al.
Molecular Cancer Therapeutics
|
June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors
Wenle Xia, Zuguo Liu, Rongrong Zong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity
Zachary C Hartman, Junping Wei, Takuya Osada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J Crosby, William Gwin, Kimberly Blackwell, et al.
Nature Communications
|
April 2, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
Li-Chung Tsao, John S Wang, Xingru Ma, et al.
JCI Insight
|
November 6, 2019
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis
Li-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2021
Adoption of community monitoring improves common pool resource management across contexts
Tara Slough, Daniel Rubenson, Ro'ee Levy, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 272) with videos related to
Sort By:
Page
of 28
Chemistry & Biology
|
September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells
Jared J Barrott, Philip F Hughes, Takuya Osada, et al.
Oncogene
|
May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
J Turpin, C Ling, E J Crosby, et al.
Human Vaccines & Immunotherapeutics
|
February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer
Gabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 27, 2026
Enhanced Efficacy of a Next-Generation EEEV Self-Replicating RNA Platform for Combination Cancer Immunotherapies
Shigeki J Miyake-Stoner, Christian J Maine, Annie C Chou, et al.
Molecular Cancer Therapeutics
|
June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors
Wenle Xia, Zuguo Liu, Rongrong Zong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity
Zachary C Hartman, Junping Wei, Takuya Osada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J Crosby, William Gwin, Kimberly Blackwell, et al.
Nature Communications
|
April 2, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
Li-Chung Tsao, John S Wang, Xingru Ma, et al.
JCI Insight
|
November 6, 2019
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis
Li-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 13, 2021
Adoption of community monitoring improves common pool resource management across contexts
Tara Slough, Daniel Rubenson, Ro'ee Levy, et al.
Page
of 28